Navigation Links
Mattel Children's Hospital UCLA launches program in nanopediatrics
Date:10/17/2008

Mattel Children's Hospital UCLA today announced the launch of the Mattel UCLA NanoPediatrics Program, which will explore the future of personalized medicine for children, including the opportunities and risks involved. The program is one of the world's first dedicated solely to nanomedicine and pediatric patients.

"Why develop a nanopediatrics program? Because children are not small adults," said Dr. Edward McCabe, physician-in-chief of Mattel Children's Hospital and founding director of the new program. "We know that drugs affect children they metabolize, excrete and may even utilize, developmentally, specific receptors differently than adults.

"Unless children are included as a research priority for the application of nanotechnology, then we will simply be applying approaches developed for adults. This flawed strategy will place children at risk, as opposed to a program in which children will be the focus from the outset."

Nanotechnology involves manipulating atoms and molecules to create tiny devices, smaller than one-thousandth the diameter of a human hair (a nanometer is one-billionth of a meter). It is anticipated that nanomedicine, fueled by nanotechnology, will enable more personalized medical care that will be both predictive and preventive.

While considerable attention has been paid to nanomedicine, UCLA's nanopediatrics program, initially organized in May 2008, may be the first initiative to examine the promises and risks of nanodiagnostics and nanotherapeutics for children in a formal and organized manner.

Created thanks to a generous $1.8 million gift from the Mattel Children's Foundation, the program will support a nanopediatrics research core and pilot funding for projects that will potentially enable investigators to obtain grants from the National Institutes of Health.

"The Mattel Children's Foundation is excited to support this groundbreaking program in nanopediatrics, which can potentially revolutionize the research and treatment of illnesses that affect young patients," said Kevin Farr, chairman of the foundation and chief financial officer of Mattel Inc. "Our philanthropic vision is to make a meaningful difference, one child at a time, and we believe that the nanopediatrics program at Mattel Children's Hospital UCLA will bring new technologies and treatments to better the lives of children battling for their health."

Projects currently underway at UCLA include the development and application of nanodiagnostic tools such as DNA-based newborn screening tests for genetic abnormalities, the development of a new generation of nanodevices for the treatment of children with genetic diseases and cancer, and the investigation of the use of nanoparticles for diagnostic imaging both during pregnancy and after birth.

The Mattel UCLA NanoPediatrics Program will partner with the California NanoSystems Institute (CNSI) at UCLA, an integrated research center established in 2000 to encourage university collaboration with industry and enable the rapid commercialization of discoveries in nanosystems. For additional information, visit www.nanopediatrics.ucla.edu.


'/>"/>

Contact: Amy Albin
aalbin@mednet.ucla.edu
310-794-8672
University of California - Los Angeles
Source:Eurekalert

Related biology technology :

1. Neurobiological Technologies Announces Amendment of License and Cooperation Agreement with Merz Pharmaceuticals and Childrens Hospital
2. George Washington University Hospital Purchases Orthocrats TraumaCad(TM) for Orthopedic Preoperative Planning
3. Childrens Hospital of Pittsburgh of UPMC Receives Prestigious Recognition for Patient Safety Efforts in National Survey
4. Bucindolol Significantly Reduces Hospitalization and Death in Heart Failure Patients With Very Favorable Genotypes
5. St. Josephs Hospital and InNexus Biotechnology Enter Collaborative Partnership
6. eGenomics Awarded First U.S. Patent Covering Rapid DNA Sequencing Technology Platform to Control Hospital-Acquired Infections
7. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
8. Truman Medical Centers Becomes One of the First Hospitals in the U.S. To Install the Worlds First Adaptive 128-slice CT Scanner
9. States First Single Incision Robotic Kidney Removal Performed at Henry Ford Hospital
10. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
11. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Calif. (PRWEB) , ... February 24, 2017 , ... Chef ... and wine scene. Making stops in several cities, she gained a number of ... adventure began in Stellenbosch, a town in South Africa’s Western Cape province. It ...
(Date:2/24/2017)...  Aethlon Medical, Inc. (Nasdaq: AEMD ), ... and CEO, Jim Joyce . In ... Saturday, Bill Gates warned world leaders that ... nuclear weapons. Mr. Gates expressed his concern, which is ... scientific terrorists have access to the necessary tools to ...
(Date:2/24/2017)...  Driven by consumers, preference towards more natural ... growing categories, finds the recently published U.S. volume ... Multi-regional Market Analysis and Opportunities study by ... "Biotechnology actives are derived from natural ... for skin and hair care applications," explains ...
(Date:2/24/2017)... NY (PRWEB) , ... February 24, 2017 , ... FireflySci, ... Founded in late 2014, FireflySci had the goal of bringing their powerful ... goal continues to shape the path that FireflySci is going on as they add ...
Breaking Biology Technology:
(Date:2/13/2017)... 2017 Former 9/11 Commission border counsel and ... Janice Kephart of Identity Strategy Partners, LLP, today ... "Executive Order: Protecting the Nation From Foreign Terrorist ... "As President Trump,s ,Travel Ban, Executive Order gains ... banned the travel ban, it is important that our ...
(Date:2/9/2017)... , Feb. 9, 2017 The biomass boiler ... of the biomass boiler market globally in terms of ... biomass boilers. The market for biomass boilers has been ... end-user, application, and country/region. The market based on feedstock ... forest residues, biogas & energy crops, urban residues, and ...
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
Breaking Biology News(10 mins):